Leptin
/api/v1/drug/leptinIndications
Sourced from openFDA- Food cravings, great appetite, regurgitation of food, nausea, eating relieves discomfort, constant belching, bloating, sluggish, overweight.ICD-10: R11.2
Dosage & administration
Sourced from openFDADIRECTIONS: 5 drops orally, 2 to 3 times per day. Take for 5 days, stop for 2 days, then repeat until you see symptoms abate. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAIf pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
FAERS reports
- 1Dizziness133%
- 2Drug Dose Omission133%
- 3Foot Fracture133%
- 4Headache133%
- 5Hyperglycaemia133%
- 6Hypersensitivity133%
- 7Hypoglycaemia133%
- 8Insulin Resistance133%
- 9Malaise133%
- 10Nasopharyngitis133%
- 11Nausea133%
- 12Vomiting133%
Literature
Recent PubMed references pinned to Leptin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- The RASA2/RASA3 ortholog RasGAP1 modulates obesity-linked phenotypes and is associated with leptin-analog signaling in Drosophila.Frontiers in endocrinology · 2026 · Moulin TC, Williams MJ, Schiöth HB, et al.PMID 42244947DOI 10.3389/fendo.2026.1773383
- Leptin in Obesity-Related Heart Failure: Pathophysiological Mechanisms and Therapeutic Implications.Comprehensive Physiology · 2026 · Li X, Wang W, Zhang Y, et al.PMID 42226483DOI 10.1002/cph4.70189
- Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date.Frontiers in endocrinology · 2026 · Van der Borght E, Van der Schueren B, Vangoitsenhoven R, et al.PMID 42222073DOI 10.3389/fendo.2026.1815903
- Hypothalamic Regulation of the Gonadal Axis and Roles of Leptin and Insulin in It.Biochemistry. Biokhimiia · 2026 · Zorina II, Derkach KV, Shpakov AO, et al.PMID 42219385DOI 10.1134/S0006297926600353
- New regulators of parathyroid hormone secretion.Current opinion in nephrology and hypertension · 2026 · Naveh-Many T, Brook E, Hassan A, et al.PMID 42199077DOI 10.1097/MNH.0000000000001190
- Protein Restriction Increases Soluble Leptin Receptor via a Leptin-Dependent Mechanism Without Affecting Leptin-Induced Appetite Suppression in Mice.Nutrients · 2026 · Uchiyama M, Toyama T, Takei Y, et al.PMID 42196942DOI 10.3390/nu18101482
- Enhanced label-free SERS detection of uremic toxins in clinical spent dialysate.Analytica chimica acta · 2026 · Lee H, Liao JD, Guo YS, et al.PMID 42191305DOI 10.1016/j.aca.2026.345601
- The Leptin Renaissance: Orchestrating the Next Endocrine Paradigm.Journal of cellular biochemistry · 2026 · Junaid M, Zeming H, Zhu Y, et al.PMID 42159080DOI 10.1002/jcb.70091
Clinical trials
The 10 most recently updated of 254 ClinicalTrials.gov registrations naming Leptin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Biomarkers in Bone Marrow Supernatant for Predicting AML ChemosensitivityRecruiting · Observational · 405 enrolled · Fujian Medical University Union HospitalNCT07587944updated 2026-05-14
- Effect of Diet Supplementation With Amaranth Protein on Mexican Children With Overweight and ObesityCompleted · Interventional · 56 enrolled · Instituto Potosino De Investigacion Cientifica Y Tecnologica ACNCT07583043updated 2026-05-13
- Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive not recruiting · Phase 3 · Interventional · 24 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT02262832updated 2026-05-12
- Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive not recruiting · Phase 2 · Interventional · 29 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT02262806updated 2026-05-12
- The Effect of Adiponectin-Leptin Ratio on Weight Loss in Patients Undergoing Sleeve Gastrectomy Due to Morbid ObesityCompleted · Observational · 78 enrolled · Sercan YUKSEL, MDNCT07564973updated 2026-05-07
- Lymphedema Surveillance StudyRecruiting · Observational · 1,250 enrolled · Memorial Sloan Kettering Cancer CenterNCT02743858updated 2026-05-07
- A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityCompleted · Phase 2 · Interventional · 392 enrolled · Eli Lilly and CompanyNCT06373146updated 2026-05-06
- Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male SubjectsNot yet recruiting · Observational · 20 enrolled · Centre Hospitalier Universitaire DijonNCT07557628updated 2026-04-29
- The Effects of Four Instant Maize Porridges on Satiety MeasuresCompleted · Interventional · 50 enrolled · PepsiCo Global R&DNCT07204470updated 2026-04-21
- Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese IndividualsNot yet recruiting · Interventional · 40 enrolled · Andalas UniversityNCT07423884updated 2026-04-13
Frequently asked questions
- What is Leptin used for?
- According to FDA labeling, Leptin carries indications including: Food cravings, great appetite, regurgitation of food, nausea, eating relieves discomfort, constant belching, bloating, sluggish, overweight.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
leptin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.